| P50 | author | Xian-Tao Zeng | Q40371853 |
| P2093 | author name string | Xian-Feng Shen | |
| | Cheng Fang | |
| | Zhi-Yuan Jian | |
| | Guo-Zheng Yu | |
| | Xue-Mei Wei | |
| P2860 | cites work | Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients | Q83749871 |
| | Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer | Q83822144 |
| | CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma | Q84275444 |
| | Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients. | Q46552631 |
| | Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. | Q46622188 |
| | A specific defect in the retinoic acid response associated with human lung cancer cell lines. | Q46934361 |
| | DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. | Q51760900 |
| | Ten-year risk of false positive screening mammograms and clinical breast examinations. | Q52245438 |
| | A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk. | Q53340358 |
| | Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. | Q53409752 |
| | Aberrant methylation of APC and RARβ2 genes in breast cancer patients. | Q53809194 |
| | DNA hypermethylation in breast cancer and its association with clinicopathological features. | Q54652899 |
| | Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions | Q61758623 |
| | Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues | Q72018784 |
| | Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR | Q73852496 |
| | Repression of transactivation of the retinoic acid receptor beta2 promoter in human breast cancer cells | Q77598277 |
| | A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women | Q80568295 |
| | Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis | Q81570140 |
| | The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling | Q24336423 |
| | Global cancer statistics, 2002 | Q27860562 |
| | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 |
| | Gene silencing in cancer in association with promoter hypermethylation | Q29617274 |
| | DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study | Q33332509 |
| | Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network | Q33403253 |
| | Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers | Q33636156 |
| | Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance | Q34150792 |
| | DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma | Q34274795 |
| | Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer | Q34305047 |
| | Breast cancer statistics and markers | Q34665620 |
| | Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual | Q35182925 |
| | Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis. | Q35195874 |
| | Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation | Q36614162 |
| | Breast cancer statistics, 2013. | Q38151550 |
| | The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review | Q38320519 |
| | Meta-Analysis of Association Between Interleukin-1β C-511T Polymorphism and Chronic Periodontitis Susceptibility | Q38367836 |
| | Meta-analysis on the association between toothbrushing and head and neck cancer. | Q38370961 |
| | Methylation Profiling of Benign and Malignant Breast Lesions and Its Application to Cytopathology | Q38450120 |
| | Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients | Q39122199 |
| | Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer. | Q39956276 |
| | Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. | Q40671507 |
| | Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells | Q40891228 |
| | The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. | Q42936748 |
| | Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes | Q43261363 |
| | Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases | Q43735744 |
| | Methylation-based analysis of circulating DNA for breast tumor screening | Q43843842 |
| | Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. | Q43973979 |
| | Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk | Q45238905 |
| | Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors | Q45877410 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tretinoin | Q29417 |
| P304 | page(s) | e0140329 | |
| P577 | publication date | 2015-10-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis | |
| P478 | volume | 10 | |